Background: A major limitation of cervical cytology is the unsuitability of proportion of smears submitted for analysis and for cytological assessment (unsatisfactory). This study examines the prevalence of unsatisfactory Pap smear, clinical history and diagnosis in the Department of Pathology, Korle-Bu Teaching Hospital (KBTH), Ghana. Materials and Methods: A retrospective review of 15,290 cases spanning 12 years (2005-2016) was carried out at the cytology unit of the Pathology Department of the KBTH. Out of the 15,290 Pap smear records retrieved, 2347 reports were excluded leaving 12,943 for the study. All unsatisfactory smear cases were analyzed and categorized using the Bethesda 2001 System. Results are presented using descriptive statistics. Results: The overall prevalence of unsatisfactory Pap smear was 402 (3.1%). Routine screening smear accounted for 115 (0.9%); reports without clinical history and diagnosis gave 21 (0.2%) and cases with clinical history and diagnosis were 287 (2.2%). The common cause of unsatisfactory Pap smear was scanty cellularity 222 (1.72%). Patient’s history accounted for the least cause of unsatisfactory Pap smear 2 (0.02%). Conclusion: Pap smear results reported as unsatisfactory could harbor cancer malignancy. Samples should be taken by well-trained persons.
References
[1]
Demay, R.M. (1996) Diseases and Conditions of the Breast in: The Art and Science of Cytopathology: Aspiration Cytology. Chicago 856-869.
[2]
Saslow, D., Solomon, D., Lawson, H.W., Killackey, M., Kulasingam, S.L., Cain, J., et al. (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. CA: A Cancer Journal for Clinicians, 62, 147-172. https://doi.org/10.3322/caac.21139
[3]
Abdali, K., Soleimani, M., Khajehei, M., Tabatabaee, H.R., Komar, P.V. and Montazer, N.R. (2010) Comparison of Pap Smear Quality with Anatomical Spatula and Convenience (Spatula-Cytobrush) Methods: A Single Blind Clinical Trial. Asian Pacific Journal of Cancer Prevention, 11, 1769-1772.
[4]
Berland, L.L., Silverman, S.G., Gore, R.M., Mayo-Smith, W.W., Megibow, A.J., Yee, J., Brink, J.A., Baker, M.E., Federle, M.P., Foley, W.D. and Francis, I.R. (2010) Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings Committee. Journal of the American College of Radiology, 7, 754-773.
https://doi.org/10.1016/j.jacr.2010.06.013
[5]
Ebu, N.I., Mupepi, S.C., Siakwa, M.P. and Sampselle, C.M. (2015) Knowledge, Practice, and Barriers toward Cervical Cancer Screening in Elmina, Southern Ghana. International Journal of Women’s Health, 7, 31-39.
https://doi.org/10.2147/IJWH.S71797
[6]
Ghana Health Service (2013) Non-communicable Disease Control Programme: Strategies for Cervical Cancer Prevention in Ghana: Planning Meeting and Training of Health Staff for HPV Demo Vaccination in Ghana.
[7]
World Health Organization (2013) Comprehensive Cervical Cancer Prevention and Control: A Healthier Future for Girls and Women. http://apps.who.int/iris/bitstream/10665/78128/3/9789241505147_eng.pdf
[8]
Adanu, R.M. (2002) Cervical Cancer Knowledge and Screening in Accra, Ghana. Journal of Women’s Health & Gender-Based Medicine, 11, 487-488. https://doi.org/10.1089/152460902760277822
[9]
WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) (2010) Human Papillomavirus and Related Cancers in World. Summary Report 2010.
[10]
Conley, M. (2012) New Guidelines Discourage Yearly Pap Tests.
[11]
Fidda, N., Miron, J., Rodgers, W.H. and Rader, A. (2004) Impact of the New Bethesda System 2001 on Specimen Adequacy of Conventional Cervicovaginal Smears. Diagnostic Cytopathology, 30, 235-239.
https://doi.org/10.1002/dc.10408
[12]
Agurto, I., Bishop, A., Sanchez, G., Betancourt, Z. and Robles, S. (2004) Perceived Barriers and Benefits to Cervical Cancer Screening in Latin America. Preventive Medicine, 39, 91-98.
https://doi.org/10.1016/j.ypmed.2004.03.040
[13]
Davey, E., Barratt, A., Irwig, L., Chan, S.F., Macaskill, P., Mannes, P., et al. (2006) Effect of Study Design and Quality on Unsatisfactory Rates, Cytology Classifications, and Accuracy in Liquid-Based Versus Conventional Cervical Cytology: A Systematic Review. The Lancet, 367, 122-132.
https://doi.org/10.1016/S0140-6736(06)67961-0
[14]
Owens, C.L., Peterson, D., Kamineni, A., Buist, D.S., Weinmann, S., Ross, T.R., Williams, A.E., Stark, A., Adams, K.F. and Field, T.S. (2013) Effects of Transitioning from Conventional Methods to Liquid-Based Methods on Unsatisfactory Papanicolaou Tests: Results from a Multicenter US Study. Cancer Cytopathology, 121, 568-575. https://doi.org/10.1002/cncy.21309
[15]
Belinson, J.L., Pan, Q.-J., Biscotti, C., Wu, L.-Y., Pretorius, R.G., Li, L., et al. (2002) Primary Screening with Liquid-Based Cytology in an Unscreened Population in Rural China, with an Emphasis on Reprocessing Unsatisfactory Samples. Acta Cytologica, 46, 470-474. https://doi.org/10.1159/000326863
[16]
Nygård, J., Sauer, T., Nygård, M., Skare, G. and Thoresen, S.Ø. (2004) CIN 2/3 and Cervical Cancer in an Organised Screening Programme after an Unsatisfactory or a Normal Pap Smear: A Seven-Year Prospective Study of the Norwegian Population-Based Screening Programme. Journal of Medical Screening, 11, 70-76.
https://doi.org/10.1258/096914104774061047
[17]
Ransdell, J.S., Davey, D.D. and Zaleski, S. (1997) Clinicopathologic Correlation of the Unsatisfactory Papanicolaou Smear. Cancer Cytopathology, 81, 139-143.
https://doi.org/10.1002/(SICI)1097-0142(19970625)81:3<139::AID-CNCR2>3.0.CO;2-M
[18]
Mood, N.I. and Eftekhar, S.J. (2004) Clinicopathologic Correlation of the Unsatisfactory Papanicolaou Smear. Acta Medica Iranica, 42, 371-374.
[19]
Gupta, S., Sodhani, P., Sardana, S., Singh, V. and Sehgal, A. (2013) Clinical Determinants and Smear Characteristics of Unsatisfactory Conventional Cervicovaginal Smears. European Journal of Obstetrics & Gynecology and Reproductive Biology, 168, 214-217. https://doi.org/10.1016/j.ejogrb.2013.01.010
[20]
McGaraghan, A. and Smith-McCune, K. (2000) Follow-Up of Unsatisfactory Papanicolaou Test Results. JAMA, 283, 1290-1291.
[21]
Lu, C.H., Chang, C.C., Ho, E.S., Chen, S.J., Lin, S.J., Fu, T.F. and Chang, M.C. (2010) Should Adequacy Criteria in Cervicovaginal Cytology Be Modified after Radiotherapy, Chemotherapy, or Hysterectomy? Cancer Cytopathology, 118, 474-481. https://doi.org/10.1002/cncy.20110
[22]
Castle, P.E., Bulten, J., Confortini, M., Klinkhamer, P., Pellegrini, A., Siebers, A.G., et al. (2010) Age-Specific Patterns of Unsatisfactory Results for Conventional Pap Smears and Liquid-Based Cytology: Data from Two Randomised Clinical Trials. BJOG: An International Journal of Obstetrics & Gynaecology, 117, 1067-1073.
https://doi.org/10.1111/j.1471-0528.2010.02650.x
[23]
Alsharif, M., McKeon, D.M., Gulbahce, H.E., Savik, K. and Pambuccian, S.E. (2009) Unsatisfactory SurePath Liquid-Based Papanicolaou Tests. Cancer Cytopathology, 117, 15-26. https://doi.org/10.1002/cncy.20009
[24]
Mirzamani, N., Chau, K., Rafael, O., Shergill, U., Sajjan, S., Sumskaya, I., et al. (2017) Quality Assessment and Improvement of “Unsatisfactory” Liquid-Based Cervicovaginal Papanicolaou Smears. Diagnostic Cytopathology, 45, 873-877. https://doi.org/10.1002/dc.23783
[25]
Katz, I.T. and Wright, A.A. (2006) Preventing Cervical Cancer in the Developing World. The New England Journal of Medicine, 354, 1110. https://doi.org/10.1056/NEJMp068031
[26]
Papillo, J.L., Zarka, M.A. and St. John, T.L. (1998) Evaluation of the ThinPrep Pap test in Clinical Practice. Acta Cytologica, 42, 203-208. https://doi.org/10.1159/000331547
[27]
Wright, T.C., Massad, L.S., Dunton, C.J., Spitzer, M., Wilkinson, E.J. and Solomon, D. (2007) 2006 Consensus Guidelines for the Management of Women with Abnormal Cervical Cancer Screening Tests. American Journal of Obstetrics and Gynecology, 197, 346-355. https://doi.org/10.1016/j.ajog.2007.07.047
[28]
Davey, D.D., Austin, R.M., Birdsong, G., Buck, H.W., Cox, J.T., Darragh, T.M., et al. (2002) ASCCP Patient Management Guidelines Pap Test Specimen Adequacy and Quality Indicators. American Journal of Clinical Pathology, 118, 714-718. https://doi.org/10.1309/6GBF-EGH8-WXDE-ANGX
[29]
Shortell, S.M., Bennett, C.L. and Byck, G.R. (1998) Assessing the Impact of Continuous Quality Improvement on Clinical Practice: What It Will Take to Accelerate Progress. The Milbank Quarterly, 76, 593-624.
https://doi.org/10.1111/1468-0009.00107
